Global Stock News

Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris

Article feature image

Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris

Strongbridge Urges Shareholders to Vote FOR All Transaction-Related Proposals
DUBLIN, Ireland and TREVOSE, Pa., Aug. 30, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (Nasdaq: SBBP) (Strongbridge) today announced that the leading independent proxy…

Click here to view the original article.

Share this article

Scroll to Top